Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues

M Parola, M Pinzani - Molecular aspects of medicine, 2019 - Elsevier
The progression of chronic liver diseases (CLD), irrespective of etiology, involves chronic
parenchymal injury, persistent activation of inflammatory response as well as sustained …

The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

K Kazankov, SMD Jørgensen, KL Thomsen… - Nature reviews …, 2019 - nature.com
Nonalcoholic fatty liver disease (NAFLD) and its inflammatory and often progressive subtype
nonalcoholic steatohepatitis (NASH) are becoming the leading cause of liver-related …

Liver macrophages in tissue homeostasis and disease

O Krenkel, F Tacke - Nature Reviews Immunology, 2017 - nature.com
Macrophages represent a key cellular component of the liver, and are essential for
maintaining tissue homeostasis and ensuring rapid responses to hepatic injury. Our …

Targeting hepatic macrophages to treat liver diseases

F Tacke - Journal of hepatology, 2017 - Elsevier
Our view on liver macrophages in the context of health and disease has been reformed by
the recognition of a remarkable heterogeneity of phagocytes in the liver. Liver macrophages …

[PDF][PDF] Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis

O Krenkel, T Puengel, O Govaere, AT Abdallah… - …, 2018 - Wiley Online Library
Macrophages are key regulators of liver fibrosis progression and regression in nonalcoholic
steatohepatitis (NASH). Liver macrophages comprise resident phagocytes, Kupffer cells …

The role of hypoxia-inducible factors in metabolic diseases

FJ Gonzalez, C Xie, C Jiang - Nature Reviews Endocrinology, 2019 - nature.com
Abstract Hypoxia-inducible factors (HIFs), a family of transcription factors activated by
hypoxia, consist of three α-subunits (HIF1α, HIF2α and HIF3α) and one β-subunit (HIF1β) …

[HTML][HTML] Macrophages and lipid metabolism

A Remmerie, CL Scott - Cellular immunology, 2018 - Elsevier
Distinct macrophage populations throughout the body display highly heterogeneous
transcriptional and epigenetic programs. Recent research has highlighted that these profiles …

Hepatic macrophages: Key players in the development and progression of liver fibrosis

D Cheng, J Chai, H Wang, L Fu, S Peng… - Liver …, 2021 - Wiley Online Library
Hepatic fibrosis is a common pathological process involving persistent liver injury with
various etiologies and subsequent inflammatory responses that occur in chronic liver …

[PDF][PDF] Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosis

C Caussy, MH Alquiraish, P Nguyen… - …, 2018 - Wiley Online Library
The optimal threshold of controlled attenuation parameter (CAP) for the detection of hepatic
steatosis using both M and XL probe is unknown in nonalcoholic fatty liver disease (NAFLD) …

[HTML][HTML] Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism

S Lefere, F Tacke - JHEP reports, 2019 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide, and
a major cause of liver cirrhosis and hepatocellular carcinoma. NAFLD is intimately linked …